These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31749367)

  • 21. The association between fasting plasma glucose and glycated hemoglobin in the prediabetes range and future development of hypertension.
    Geva M; Shlomai G; Berkovich A; Maor E; Leibowitz A; Tenenbaum A; Grossman E
    Cardiovasc Diabetol; 2019 Apr; 18(1):53. PubMed ID: 31029146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediabetes diagnosis is associated with the progression of coronary artery calcification: The Kangbuk Samsung Health Study.
    Choi IY; Chang Y; Cho Y; Kang J; Jung HS; Wild SH; Byrne CD; Ryu S
    Diabetes Obes Metab; 2022 Nov; 24(11):2118-2126. PubMed ID: 35695046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Impact of Prediabetes on Two-Year Clinical Outcomes in Patients Undergoing Elective Percutaneous Coronary Intervention.
    Choi WG; Rha SW; Choi BG; Choi SY; Byun JK; Mashaly A; Park Y; Jang WY; Kim W; Choi JY; Park EJ; Na JO; Choi CU; Kim EJ; Park CG; Seo HS
    Yonsei Med J; 2018 Jun; 59(4):489-494. PubMed ID: 29749131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Silent" Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study.
    von Birgelen C; Kok MM; Sattar N; Zocca P; Doelman C; Kant GD; Löwik MM; van der Heijden LC; Sen H; van Houwelingen KG; Stoel MG; Louwerenburg JHW; Hartmann M; de Man FHAF; Linssen GCM; Doggen CJM; Tandjung K
    JACC Cardiovasc Interv; 2018 Mar; 11(5):448-459. PubMed ID: 29454724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-year clinical outcome in all-comers with "silent" diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug-eluting stents: From the BIO-RESORT Silent Diabetes study.
    Ploumen EH; Buiten RA; Kok MM; Doggen CJM; van Houwelingen KG; Stoel MG; de Man FHAF; Hartmann M; Zocca P; Linssen GCM; Doelman C; Kant GD; von Birgelen C
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):E110-E118. PubMed ID: 31625262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016.
    Andes LJ; Cheng YJ; Rolka DB; Gregg EW; Imperatore G
    JAMA Pediatr; 2020 Feb; 174(2):e194498. PubMed ID: 31790544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value of hemoglobin A1c and fasting plasma glucose levels in coronary artery bypass grafting patients with undiagnosed diabetes mellitus.
    Tekumit H; Cenal AR; Polat A; Uzun K; Tataroglu C; Akinci E
    Ann Thorac Surg; 2010 May; 89(5):1482-7. PubMed ID: 20417764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycosylated hemoglobin levels and the risk for contrast-induced nephropathy in diabetic patients undergoing coronary arteriography/percutaneous coronary intervention.
    Zhang H; Fu H; Fu X; Zhang J; Zhang P; Yang S; Zeng Z; Fu N; Guo Z
    BMC Nephrol; 2021 Jun; 22(1):206. PubMed ID: 34078303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention.
    Takahashi S; Shimada K; Miyauchi K; Miyazaki T; Sai E; Ogita M; Tsuboi S; Tamura H; Okazaki S; Shiozawa T; Ouchi S; Aikawa T; Kadoguchi T; Al Shahi H; Yoshihara T; Hiki M; Isoda K; Daida H
    Cardiovasc Diabetol; 2016 Oct; 15(1):145. PubMed ID: 27729086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Secondary Prevention Status between Percutaneous Coronary Intervention and Coronary Artery Bypass Patients.
    Gao XQ; Li Y; Jiang ZL
    Arq Bras Cardiol; 2017 Nov; 109(5):466-474. PubMed ID: 29267627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. General glycosylated hemoglobin goals potentially increase myocardial infarction severity in diabetes patients with comorbidities: Insights from a nationwide multicenter study.
    Che Q; Zhang Y; Wang J; Wan Z; Fu X; Chen J; Yan H; Chen Y; Ge J; Chen D; Huo Y
    J Diabetes Investig; 2020 Nov; 11(6):1498-1506. PubMed ID: 32383543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between the Finnish Diabetes risk Score and the severity of coronary artery disease.
    Djurić P; Mladenović Z; Grdinić A; Tavčiovski D; Spasić M; Davičević-Elez Z
    Vojnosanit Pregl; 2014 May; 71(5):474-80. PubMed ID: 26137713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of glycated hemoglobin on heart function of the patients with revascularization of coronary artery.
    Sun XQ; Bao BN; Gao XY; Yan DE; Zhou YS
    Int J Clin Exp Pathol; 2015; 8(6):7181-8. PubMed ID: 26261612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemoglobin A1c in combination with fasting plasma glucose trumps fasting plasma glucose alone as predictive indicators for diabetes mellitus: an ambidirectional cohort study of Thai people with impaired fasting glucose.
    Thamakaison S; Anothaisintawee T; Sukhato K; Unwanatham N; Rattanasiri S; Reutrakul S; Thakkinstian A
    BMJ Open Diabetes Res Care; 2021 Nov; 9(2):. PubMed ID: 34845059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonlinear association of 1,5-anhydroglucitol with the prevalence and severity of coronary artery disease in chinese patients undergoing coronary angiography.
    Yang R; Zhang W; Wang X; Wang S; Zhou Q; Li H; Mu H; Yu X; Ji F; Dong J; Chen W
    Front Endocrinol (Lausanne); 2022; 13():978520. PubMed ID: 36133308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study.
    Chen ZW; Yang HB; Chen YH; Ma JY; Qian JY; Ge JB
    BMC Cardiovasc Disord; 2017 Feb; 17(1):69. PubMed ID: 28241795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycaemic control and restenosis after percutaneous coronary interventions in patients with diabetes mellitus: a report from the Insulin Diabetes Angioplasty study.
    Hage C; Norhammar A; Grip L; Malmberg K; Sarkar N; Svane B; Rydén L
    Diab Vasc Dis Res; 2009 Apr; 6(2):71-9. PubMed ID: 20368196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of unknown diabetes and prediabetes on clinical outcomes in "nondiabetic" Chinese patients after a primary coronary intervention.
    Wang H; Song Y; Tang X; Xu J; Jiang P; Jiang L; Gao Z; Chen J; Song L; Zhang Y; Zhao X; Qiao S; Yang Y; Gao R; Xu B; Yuan J; Gao L
    Nutr Metab Cardiovasc Dis; 2020 Apr; 30(4):644-651. PubMed ID: 32143897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients.
    Verdoia M; Schaffer A; Barbieri L; Di Giovine G; Marino P; Suryapranata H; De Luca G;
    J Diabetes Complications; 2015; 29(4):517-22. PubMed ID: 25736187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association Between Glycosylated Hemoglobin Level and Cardiovascular Outcomes in Diabetic Patients After Percutaneous Coronary Intervention.
    Zheng J; Cheng J; Zhang Q; Qi C; Wang T; Xiao X
    Medicine (Baltimore); 2016 May; 95(19):e3696. PubMed ID: 27175711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.